Re-188 labelled antibodies

Applied Radiation and Isotopes

Volumn 47, Issue 1, 1996, Pages 7-14

  Rhodes, B A ^a   Lambert, C R ^a   Marek, M J ^a   Knapp Jr , F F ^b   Harvey, E B ^c  

^a RhoMed Inc   (United States)

^b OAK RIDGE NATIONAL LABORATORY   (United States)

^c Sterling Winthrop   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY B.72.3; RHENIUM 188;

ANIMAL EXPERIMENT; ARTICLE; CANCER GRAFT; CONTROLLED STUDY; ISOTOPE LABELING; MOUSE; PHARMACOKINETICS; PRIORITY JOURNAL;

EID: 0030040422     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8043(95)00262-6     Document Type: Article

References (28)

1. Abdel-Nabi H., Doerr R. J., Chan H.-W., Balu D., Schmelter R. F. andMaguire R. T. (1990) In-111-labelled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results. Radiology 175, 163-171.
2. 99mTc. Nucl. Med. Biol. 19, 445-454.
3. Balchot J., Herment J. and Moussa A. (1969) Generator of W-188/Re-188. Int. J. Appl. Radiot. Isot. 20, 467.
4. Breitz H. B., Fisher D. R., Weiden P. L., Durham J. S., Ratliff B. A., Bjorn M. J., Beaumier P. L. and Abrams P. G. (1993) Dosimetry of rhenium-186-labelled monoclonal antibodies: methods, prediction from technetium-99m-labelled antibodies and results of phase I trials. J. Nucl. Med. 34, 906-917.
5. Callahan A. P., Rice D. E. and Knapp F. F. Jr. (1989) Re-188 for therapeutic applications from an alumina based W-188/Re-188 radionuclide generator system. Nuc-Compact 20, 3.
6. Colcher D., Horan Hand P., Nuti M. and Schlom J. (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc. Natl. Acad. Sci. U.S.A. 78, 3199-3203.
7. Early J. F., Durack L., Williams D. and Vanderheyden J.-L. (1990) Considerations for imaging Re-188 and Re-186 isotopes. Clin. Nucl. Med. 15, 911-916.
8. Esteban S. M., Colcher, D., Sugarbake P., Carrasquillo J. A., Brant G., Thor A., Reynolds J. C., Larson S. M. and Schlom J. (1987) Int. J. Cancer 39, 56-59.
9. Fritzberg A. R., Vanderheyden J.-L., Morgan A. C., Schroff R. W., Abrams P. G. (1990) Rhenium-186/-188 labelled antibodies for radioimmunotherapy. In Technetium and Rhenium in Chemistry and Nuclear Medicine, (Nicolini M., Brandoli G. and Mazzi U., Eds), pp. 615-621. Raven Press, New York.
10. 186Re-labelled NR-LU-10 whole antibody in LS174T colonic tumor bearing mice. Cancer Res 50, 7973-7978.
11. Griffiths G. L., Knapp F. F. Jr., Callahan A. P., Chang C-H., Goldenberg D. M. and Hansen H. J. (1991) Direct radiolabelling of monoclonal antibodies with generator produced rhenium-188 for radioimmunotherapy; labelling and animal biodistribution studies. Cancer Res 51, 4594-4602.
12. Hnatowich D. J., Mardirossian G., Rusckowski M. Fogarasi M., Virzi F. and Winnard P. (1993a) Directly and indirectly technetium-99m-labelled antibodies - a comparison of in vitro and animal in vivo properties. J. Nucl. Med. 34, 109-119.
13. Hnatowich D. J., Virzi F., Fogarasi M., Rusckowski M. and Winnard P. (1993b) Can a cysteine-challenge assay predict the in vivo stability and biodistribution of Tc-99m labelled to antibodies? J. Nucl. Med. 34, 49P (Abs. No. 231).
14. John E., Thakur M. L., DeFulvio, J., McDevitt M. R. and Damjanov I. (1993) Rhenium-186-labelled monoclonal antibodies for radioimmunotherapy: preparation and evaluation. J. Nucl. Med. 34, 260-267.
15. Knapp F. F. Jr., Lisic E. C., Mirzadeh S. and Callahan A. P. (1993) Tungsten-188/Carrier-Free rhenium-188 perrhenic acid generator system. U.S. Patent No. 5,186,913.
16. Neal C. E. and Abdel-Nabi H. (1994) Clinical immunoscintigraphy of recurrent colorectal carcinoma. Appl. Radiol. 23, 32-39.
17. Pant K. D., Blank E. W. and Ceriani R. L. (1991) Radiolabelling of monoclonal antibodies with Re-186. Antibody, Immunoconj Radiopharm 4, 219 (Abs.).
18. 186Re: potential for radioimmunotherapy. Nucl. Med. Biol. 33, 447-451.
19. Rhodes B. A., Zamora P. O., Marek M. J. Stay J. E., Buhler K. R., and Vessella R. L. (1993) Direct labelling of antibodies with Re-186. Diagn. Oncol. 3, 29.
20. Rhodes B. A., Torvestad D. A., Breslow K., Sharma S. D. and Wall F. J. (1980) A kit for direct labelling of antibody and antibody fragments with Tc-99m. /. Nucl. Med. 21, 54.
21. 99mTc-labelling of proteins and peptides: factors that alter radiochemical yields and in vivo stability. Technetium in Chem. and Nucl. Med. 4, 281-286.
22. Sharkey R. M., Goldenberg D. M., Levine G., Vagg R., Ahmad M., Pawlyk D., Siegel J. A., Griffiths G. L., Hansen H. J., Callahan A. P., Knapp F. F. Jr, Swayne L. C. and Conte P. J. (1993) Phase-1 Radioimmunotherapy (RAIT) using a rhenium-188-labelled murine monoclonal antibody (MAb). J. Nucl. Med. 34, 54P (Abs. No. 209).
23. Stray J. E., Vessella R. L., Buhler K. R., Harvey E. B., Marek M. J. and Rhodes B. A. (1993) Direct labelling of the anti-renal cell carcinoma antibody A6H with rhenium-186: targeting of human renal cell carcinoma xenografts. Antibody, Immunoconj. Radiopharm. 6, 84 (Abs. No. 71).
24. Thor A., Ohuchi N., Szpak C. A., Johnston W. W. and Schlom J. (1986) Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 46, 3118-3124.
25. Thrall J. H., Freitas J. E., Swanson D., Rogers W. L., Clare J. M., Brown M. L. and Pitt B. (1978) Clinical comparison of cardiac blood pool visualization with technetium-99m red blood cells labelled in vivo and with technetium-99m human serum albumin. J. Nucl. Med. 19, 796-803.
26. 186Re-labelled antibodies be predicted in vitro by challenge with cysteine? J. Nucl. Med. 35, 246P.
27. Zamora P. O., Rhodes B. A., Sass K. A., Budd P., Lambert C. A., Cardillo A. and Marek M. J. (1993) A simple TLC assay to assess the percent immunoreactive fraction (IF) of radiolabelled antibodies. J. Nucl. Med. 35, 231P.
28. Zamora P. O., Sass K., Cardillo A. S., Lambert C. R., Budd P., Marek M. J. and Rhodes B. A. (1994) Affinity thin layer chromatography (ATLC) test of immunoreactive fraction of radiolabelled antibodies. BioTechniques 16, 306-311.